{"ACN": {"Ticker": "ACN", "Company": "Accenture", "Sector": "Information Technology", "Updated": "2023-01-30", "Rating": [{"Date": "2023-01-30", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$289"}, {"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Underweight", "Target_Change": "$268"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Wells Fargo", "Piper Sandler"], "Price_Target": 278.5}, "AMZN": {"Ticker": "AMZN", "Company": "Amazon", "Sector": "Consumer Discretionary", "Updated": "2023-01-30", "Rating": [{"Date": "2023-01-30", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$140 to $130"}, {"Date": "2023-01-25", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$121 to $118"}, {"Date": "2023-01-24", "Rating": "Reiterated", "Organization": "Telsey Advisory Group", "Rating_Change": "Outperform", "Target_Change": "$140 to $125"}, {"Date": "2023-01-18", "Rating": "Reiterated", "Organization": "MKM Partners", "Rating_Change": "Buy", "Target_Change": "$145 to $125"}, {"Date": "2023-01-04", "Rating": "Initiated", "Organization": "New Street", "Rating_Change": "Buy", "Target_Change": "$130"}, {"Date": "2022-11-15", "Rating": "Initiated", "Organization": "MoffettNathanson", "Rating_Change": "Outperform", "Target_Change": "$118"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Barclays", "Telsey Advisory Group", "MoffettNathanson", "New Street", "MKM Partners", "UBS"], "Price_Target": 124.33}, "CL": {"Ticker": "CL", "Company": "Colgate-Palmolive", "Sector": "Consumer Staples", "Updated": "2023-01-30", "Rating": [{"Date": "2023-01-30", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$82"}, {"Date": "2022-11-22", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": ""}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Wolfe Research", "Morgan Stanley"], "Price_Target": 82.0}, "EMN": {"Ticker": "EMN", "Company": "Eastman Chemical", "Sector": "Materials", "Updated": "2023-01-30", "Rating": [{"Date": "2023-01-30", "Rating": "Downgrade", "Organization": "Vertical Research", "Rating_Change": "Buy to Hold", "Target_Change": "$94 to $92"}, {"Date": "2023-01-30", "Rating": "Downgrade", "Organization": "Scotiabank", "Rating_Change": "Sector Outperform to Sector Perform", "Target_Change": "$100 to $90"}, {"Date": "2023-01-11", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$98 to $108"}, {"Date": "2022-11-08", "Rating": "Upgrade", "Organization": "Tudor, Pickering, Holt & Co.", "Rating_Change": "Hold to Buy", "Target_Change": ""}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Vertical Research", "BofA Securities", "Scotiabank", "Tudor, Pickering, Holt & Co."], "Price_Target": 96.67}, "EW": {"Ticker": "EW", "Company": "Edwards Lifesciences", "Sector": "Health Care", "Updated": "2023-01-30", "Rating": [{"Date": "2023-01-30", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$95 to $80"}, {"Date": "2022-12-06", "Rating": "Downgrade", "Organization": "Stifel", "Rating_Change": "Buy to Hold", "Target_Change": "$95 to $75"}], "Score": -1.5, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Stifel", "Piper Sandler"], "Price_Target": 77.5}, "FRT": {"Ticker": "FRT", "Company": "Federal Realty Investment Trust", "Sector": "Real Estate", "Updated": "2023-01-30", "Rating": [{"Date": "2023-01-30", "Rating": "Upgrade", "Organization": "Compass Point", "Rating_Change": "Neutral to Buy", "Target_Change": "$125"}, {"Date": "2022-12-16", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$118 to $115"}, {"Date": "2022-12-15", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$115 to $112"}], "Score": -0.67, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Compass Point", "JP Morgan", "Piper Sandler"], "Price_Target": 117.33}, "GM": {"Ticker": "GM", "Company": "General Motors", "Sector": "Consumer Discretionary", "Updated": "2023-01-30", "Rating": [{"Date": "2023-01-30", "Rating": "Downgrade", "Organization": "Berenberg", "Rating_Change": "Buy to Hold", "Target_Change": "$45 to $41"}, {"Date": "2022-11-10", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}], "Score": -1.5, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Berenberg", "Wolfe Research"], "Price_Target": 41.0}, "LMT": {"Ticker": "LMT", "Company": "Lockheed Martin", "Sector": "Industrials", "Updated": "2023-01-30", "Rating": [{"Date": "2023-01-30", "Rating": "Upgrade", "Organization": "DZ Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$523"}, {"Date": "2023-01-13", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Sell", "Target_Change": "$388 to $332"}, {"Date": "2023-01-06", "Rating": "Downgrade", "Organization": "Vertical Research", "Rating_Change": "Buy to Hold", "Target_Change": "$491"}, {"Date": "2022-12-15", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$506 to $542"}, {"Date": "2022-12-08", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$546"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Goldman", "Vertical Research", "DZ Bank", "Morgan Stanley", "Citigroup"], "Price_Target": 486.8}, "MMC": {"Ticker": "MMC", "Company": "Marsh & McLennan", "Sector": "Financials", "Updated": "2023-01-30", "Rating": [{"Date": "2023-01-30", "Rating": "Reiterated", "Organization": "MKM Partners", "Rating_Change": "Neutral", "Target_Change": "$160 to $175"}, {"Date": "2023-01-20", "Rating": "Initiated", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform", "Target_Change": "$168"}, {"Date": "2023-01-09", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$181 to $178"}, {"Date": "2022-12-23", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$157"}, {"Date": "2022-12-15", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$185"}, {"Date": "2022-11-08", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$185"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Credit Suisse", "Jefferies", "Atlantic Equities", "BMO Capital Markets", "MKM Partners", "Citigroup"], "Price_Target": 174.67}, "ODFL": {"Ticker": "ODFL", "Company": "Old Dominion Freight Line", "Sector": "Industrials", "Updated": "2023-01-30", "Rating": [{"Date": "2023-01-30", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Neutral to Underperform", "Target_Change": "$323"}, {"Date": "2023-01-17", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Neutral", "Target_Change": "$266 to $334"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["BofA Securities", "Credit Suisse"], "Price_Target": 328.5}, "REGN": {"Ticker": "REGN", "Company": "Regeneron Pharmaceuticals", "Sector": "Health Care", "Updated": "2023-01-30", "Rating": [{"Date": "2023-01-30", "Rating": "Upgrade", "Organization": "Cowen", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$775 to $875"}, {"Date": "2023-01-20", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$850"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Cowen", "JP Morgan"], "Price_Target": 862.5}, "TSLA": {"Ticker": "TSLA", "Company": "Tesla", "Sector": "Consumer Discretionary", "Updated": "2023-01-30", "Rating": [{"Date": "2023-01-30", "Rating": "Upgrade", "Organization": "Berenberg", "Rating_Change": "Hold to Buy", "Target_Change": "$255 to $200"}, {"Date": "2023-01-27", "Rating": "Reiterated", "Organization": "Argus", "Rating_Change": "Buy", "Target_Change": "$374 to $257"}, {"Date": "2023-01-23", "Rating": "Reiterated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$299 to $245"}, {"Date": "2023-01-13", "Rating": "Downgrade", "Organization": "Guggenheim", "Rating_Change": "Neutral to Sell", "Target_Change": ""}, {"Date": "2023-01-09", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$275 to $135"}, {"Date": "2023-01-05", "Rating": "Upgrade", "Organization": "Edward Jones", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2023-01-03", "Rating": "Reiterated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$348 to $299"}, {"Date": "2023-01-03", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Underweight", "Target_Change": "$150 to $125"}, {"Date": "2023-01-03", "Rating": "Reiterated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$235 to $205"}, {"Date": "2022-12-29", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$330 to $250"}, {"Date": "2022-12-28", "Rating": "Reiterated", "Organization": "Robert W. Baird", "Rating_Change": "Outperform", "Target_Change": "$316 to $252"}, {"Date": "2022-12-23", "Rating": "Reiterated", "Organization": "Wedbush", "Rating_Change": "Outperform", "Target_Change": "$250 to $175"}, {"Date": "2022-12-22", "Rating": "Reiterated", "Organization": "Canaccord Genuity", "Rating_Change": "Buy", "Target_Change": "$304 to $275"}, {"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "Oppenheimer", "Rating_Change": "Outperform to Perform", "Target_Change": ""}, {"Date": "2022-11-23", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Sell to Neutral", "Target_Change": "$141.33 to $176"}], "Score": 1.07, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 15, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Truist", "Edward Jones", "Canaccord Genuity", "Wedbush", "Goldman", "Oppenheimer", "Argus", "JP Morgan", "Robert W. Baird", "BofA Securities", "Berenberg", "Guggenheim", "Morgan Stanley", "Citigroup"], "Price_Target": 216.17}}